aTyr Pharma
Price & Volume
Stats
See more52W Range | $0.64-$7.29 |
Market Cap | $69.8M |
Shares Short | 30M |
Financials
See moreRevenue (12 Mos) | $190,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$61.3M |
Diluted EPS | -$0.83 |
News
See moreYahoo Finance • last month
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class Action – Contact The Gross Law Firm to Learn More
Yahoo Finance • last month
ATYR DEADLINE ALERT: Hagens Berman Alerts aTyr Pharma (ATYR) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action
Yahoo Finance • last month
DEADLINE ALERT for MRX, ATYR, and WPP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Yahoo Finance • last month
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
About
CEO | Dr. Sanjay S. Shukla M.D., M.S. |
Address | 10240 Sorrento Valley Road, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 56 |
